Cerium oxide NPs mitigate the amyloid formation of α-synuclein and associated cytotoxicity

References

• Marei HE, Althani A, Lashen S, Cenciarelli C, Hasan A. Genetically unmatched human iPSC and ESC exhibit equivalent gene expression and neuronal differentiation potential. Sci Rep. 2017;7(1):17504–17510. doi:10.1038/s41598-017-17882-129235536
   PubMedGoogle Scholar
• Wills J, Credle J, Haggerty T, Lee J-H, Oaks AW, Sidhu A. Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson’s disease. PLoS One. 2011;6(3):e17953–9. doi:10.1371/journal.pone.001795321445308
   PubMedGoogle Scholar
• Kaushik AC, Bharadwaj S, Kumar S, Wei D-Q. Nano-particle mediated inhibition of Parkinson’s disease using computational biology approach. Sci Rep. 2018;8(1):9169–9179. doi:10.1038/s41598-018-27580-129907754
   PubMedGoogle Scholar
• Jiang T, Sun Q, Chen S. Oxidative stress: a major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease. Prog Neurobiol. 2016;147:1–19. doi:10.1016/j.pneurobio.2016.07.00527769868
   PubMed Web of Science ®Google Scholar
• Elmann A, Telerman A, Ofir R, Kashman Y, Lazarov O. β-amyloid cytotoxicity is prevented by natural achillolide A. J Nat Med. 2018;72(3):626–631. doi:10.1007/s11418-018-1191-029546477
   PubMedGoogle Scholar
• Fink AL. The Aggregation and fibrillation of α-synuclein. Acc Chem Res. 2006;39(9):628–634. doi:10.1021/ar050073t16981679
   PubMed Web of Science ®Google Scholar
• Adamczyk A, Solecka J, Strosznajder J. Expression of a-synuclein in different brain parts. J Physiol Pharmacol. 2005;56(1):29–37.15795473
   PubMed Web of Science ®Google Scholar
• Panza F, Lozupone M, Logroscino G, Imbimbo BP. A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease. Nat Rev Neurol. 2019;1:1–10.
   Google Scholar
• Alvarez YD, Fauerbach JA, Pellegrotti JV, Jovin TM, Jares-Erijman EA, Stefani FD. Influence of gold nanoparticles on the kinetics of alpha-synuclein aggregation. Nano Lett. 2013;13(12):6156–6163. doi:10.1021/nl403490e24219503
   PubMedGoogle Scholar
• Mahmoudi M, Hosseinkhani H, Hosseinkhani M, et al. Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chem Rev. 2011;111(2):253–280. doi:10.1021/cr100183221077606
   PubMedGoogle Scholar
• Padmanabhan P, Kumar A, Kumar S, Chaudhary RK, Gulyas B. Nanoparticles in practice for molecular-imaging applications: an overview. Acta Biomater. 2016;41:1–16. doi:10.1016/j.actbio.2016.06.00327265153
   PubMed Web of Science ®Google Scholar
• Mohammadi S, Nikkhah M. TiO2 nanoparticles as potential promoting agents of fibrillation of α-synuclein, a parkinson’s disease-related protein. Iran J Biotechnol. 2017;15(2):87–97. doi:10.15171/ijb.151929845055
   PubMedGoogle Scholar
• Wu J, Wang C, Sun J, Xue Y. Neurotoxicity of silica nanoparticles: brain localization and dopaminergic neurons damage pathways. ACS Nano. 2011;5(6):4476–4489. doi:10.1021/nn103530b21526751
   PubMed Web of Science ®Google Scholar
• Naz S, Beach J, Heckert B, et al. Cerium oxide nanoparticles: a ‘radical’approach to neurodegenerative disease treatment. Nanomedicine. 2017;12(5):545–553. doi:10.2217/nnm-2016-039928181459
   PubMed Web of Science ®Google Scholar
• Paul A, Hasan A, Rodes L, Sangaralingam M, Prakash S. Bioengineered baculoviruses as new class of therapeutics using micro and nanotechnologies: principles, prospects and challenges. Adv Drug Del Rev. 2014;71:115–130. doi:10.1016/j.addr.2014.01.004
   PubMed Web of Science ®Google Scholar
• Korsvik C, Patil S, Seal S, Self WT. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem Commun (Camb). 2007;10:1056–1058. doi:10.1039/b615134e17325804
   PubMed Web of Science ®Google Scholar
• Dahle JT, Arai Y. Environmental geochemistry of cerium: applications and toxicology of cerium oxide nanoparticles. Int J Environ Res Public Health. 2015;12(2):1253–1278. doi:10.3390/ijerph12020125325625406
   PubMed Web of Science ®Google Scholar
• Sayle TX, Parker SC, Catlow CR. The role of oxygen vacancies on ceria surfaces in the oxidation of carbon monoxide. Surface Science 1994;316(3):329–336.
   Google Scholar
• Asati A, Santra S, Kaittanis C, Nath S, Perez JM. Oxidase-like activity of polymer-coated cerium oxide nanoparticles. Angew Chem. 2009;48(13):2308–2312. doi:10.1002/anie.20080527919130532
   PubMedGoogle Scholar
• Karakoti A, Singh S, Dowding JM, Seal S, Self WT. Redox-active radical scavenging nanomaterials. Chem Soc Rev. 2010;39(11):4422–4432. doi:10.1039/b919677n20717560
   PubMedGoogle Scholar
• Xu C, Qu X. Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Mater. 2014;6(3):90–99. doi:10.1038/am.2013.88
   Web of Science ®Google Scholar
• Eskandari N, Babadaei MMN, Nikpur S, et al. Biophysical, docking, and cellular studies on the effects of cerium oxide nanoparticles on blood components: in vitro. Int J Nanomedicine. 2018;13:4575–4585. doi:10.2147/IJN.S17216230127607
   PubMed Web of Science ®Google Scholar
• González-Lizárraga F, Socías SB, Ávila CL, et al. Repurposing doxycycline for synucleinopathies: remodelling of α-synuclein oligomers towards non-toxic parallel beta-sheet structured species. Sci Rep. 2017;7:41755. doi:10.1038/srep4175528155912
   PubMed Web of Science ®Google Scholar
• Cabaleiro-Lago C, Szczepankiewicz O, Linse S. The effect of nanoparticles on amyloid aggregation depends on the protein stability and intrinsic aggregation rate. Langmuir. 2012;28(3):1852–1857. doi:10.1021/la203078w22168533
   PubMedGoogle Scholar
• Mahdavimehr M, Meratan AA, Ghobeh M, Ghasemi A, Saboury AA, Nemat-Gorgani M. Inhibition of HEWL fibril formation by taxifolin: mechanism of action. PLoS One. 2017;12(11): 0187841–49. doi:10.1371/journal.pone.0187841
   PubMed Web of Science ®Google Scholar
• Ritchie DW, Venkatraman V. Ultra-fast FFT protein docking on graphics processors. Bioinformatics. 2010;26(19):2398–2405. doi:10.1093/bioinformatics/btq44420685958
   PubMed Web of Science ®Google Scholar
• Rappé AK, Casewit CJ, Colwell K, Goddard WA III, Skiff WM. UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations. J Am Chem Soc. 1992;114(25):10024–10035. doi:10.1021/ja00051a040
   Web of Science ®Google Scholar
• Babadaei MMN, Moghaddam MF, Solhvand S, et al. Biophysical, bioinformatical, cellular, and molecular investigations on the effects of graphene oxide nanosheets on the hemoglobin structure and lymphocyte cell cytotoxicity. Int J Nanomedicine. 2018;13:6871–6877. doi:10.2147/IJN.S17404830498348
   PubMed Web of Science ®Google Scholar
• Hanada S, Fujioka K, Inoue Y, Kanaya F, Manome Y, Yamamoto K. Cell-based in vitro blood–brain barrier model can rapidly evaluate nanoparticles’ brain permeability in association with particle size and surface modification. Int J Mol Sci. 2014;15(2):1812–1825. doi:10.3390/ijms1502181224469316
   PubMed Web of Science ®Google Scholar
• Shilo M, Sharon A, Baranes K, Motiei M, Lellouche J-PM, Popovtzer R. The effect of nanoparticle size on the probability to cross the blood-brain barrier: an in-vitro endothelial cell model. J Nanobiotechnology. 2015;13(1):19–29. doi:10.1186/s12951-015-0075-725880565
   PubMedGoogle Scholar
• Qadeer A, Rabbani G, Zaidi N, Ahmad E, Khan JM, Khan RH. 1-Anilino-8-naphthalene sulfonate (ANS) is not a desirable probe for determining the molten globule state of chymopapain. PLoS One. 2012;7(11):e50633. doi:10.1371/journal.pone.005063323209794
   PubMedGoogle Scholar
• Mohammad-Beigi H, Hosseini A, Adeli M, et al. Mechanistic understanding of the interactions between nano-objects with different surface properties and α-synuclein. ACS Nano. 2019;1:1–10.
   Google Scholar
• Murakami K, Murata N, Noda Y, et al. SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid beta protein oligomerization and memory loss in mouse model of Alzheimer disease. J Biol Chem. 2011;286(52):44557–44568. doi:10.1074/jbc.M111.27920822072713
   PubMed Web of Science ®Google Scholar
• Dowding JM, Dosani T, Kumar A, Seal S, Self WT. Cerium oxide nanoparticles scavenge nitric oxide radical (NO). Chem Commun (Camb). 2012;48(40):4896–4898. doi:10.1039/c2cc30485f22498787
   PubMed Web of Science ®Google Scholar
• Cimini A, D’Angelo B, Das S, et al. Antibody-conjugated PEGylated cerium oxide nanoparticles for specific targeting of Aβ aggregates modulate neuronal survival pathways. Acta Biomater. 2012;8(6):2056–2067. doi:10.1016/j.actbio.2012.01.03522343002
   PubMed Web of Science ®Google Scholar
• Dowding JM, Song W, Bossy K, et al. Cerium oxide nanoparticles protect against Aβ-induced mitochondrial fragmentation and neuronal cell death. Cell Death Differ. 2014;21(10):1622–1632. doi:10.1038/cdd.2014.7224902900
   PubMed Web of Science ®Google Scholar
• Seal S, Das S, Cimini A, D’angelo B. Nanoparticles of cerium oxide targeted to an amyloid beta antigen of alzheimer’s disease and associated methods. Google Pat. 2016;1:1.2.
   Google Scholar
• Sekar G, Kumar NP, Mukherjee A, Chandrasekaran N. Cerium oxide nanoparticles promote HSA fibrillation in vitro. Int J Biol Macromol. 2017;103:1138–1145. doi:10.1016/j.ijbiomac.2017.05.18028579458
   PubMedGoogle Scholar
• John T, Gladytz A, Kubeil C, Martin LL, Risselada HJ, Abel B. Impact of nanoparticles on amyloid peptide and protein aggregation: a review with a focus on gold nanoparticles. Nanoscale. 2018;10(45):20894–20913. doi:10.1039/c8nr04506b30225490
   PubMedGoogle Scholar
• Mandal S, Debnath K, Jana NR, Jana NR. Trehalose-functionalized gold nanoparticle for inhibiting intracellular protein aggregation. Langmuir. 2017;33(49):13996–14003. doi:10.1021/acs.langmuir.7b0220229125765
   PubMedGoogle Scholar
• Asthana S, Hazarika Z, Nayak PS, et al. Insulin adsorption onto zinc oxide nanoparticle mediates conformational rearrangement into amyloid-prone structure with enhanced cytotoxic propensity. Biochim Biophys Acta Gen Subj. 2019;1863(1):153–166. doi:10.1016/j.bbagen.2018.10.00430315849
   PubMed Web of Science ®Google Scholar
• Samai B, Basu A, Mati SS, Bhattacharya SC. Antiamyloid activity of functionalized cerium oxide nanoparticle on lysozyme fibrillation: spectroscopic and microscopic investigation. Materialia. 2019;6:100285–100295. doi:10.1016/j.mtla.2019.100285
   Google Scholar
• Javdani N, Rahpeyma SS, Ghasemi Y, Raheb J. Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process. Int J Nanomedicine. 2019;14:799–808. doi:10.2147/IJN.S19035430774334
   PubMedGoogle Scholar